16. Vincent
VINCENT
Three days pass without feeling like three days.
The residence operates on a schedule I set and she has already decoded.
I know this because by the second day she was raising questions about distribution logistics that could only have been constructed from an understanding of when the staff move through which corridors and how long each interval runs.
She did not ask about the schedule directly.
The questions she chose required knowing it.
That is a distinction I find, against all professional judgment, more interesting than threatening.
She has her phone for the failsafe check-ins.
Nothing else reaches her. No outside calls, no data beyond what I allow through the network I control.
She has not tested the boundary. She has, instead, been using the hours to think, which is more dangerous than testing boundaries and which she is aware I know.
Graham calls on the second morning.
"The investigation file," he says. "Should I consider it closed?"
A silence opens between us. Graham has seen enough of my decisions to understand that silence here is not uncertainty.
"Hold it where it is," I say.
He absorbs this. Then, with the careful precision he brings to questions he already knows the answer to: "Should I assume the situation is being managed outside normal channels."
"That is a reasonable assumption."
"And the relevant party is contained."
"For the moment."
He says nothing further. This is what eleven years produce. A man who understands that some situations are not his to ask about, and who asks about them anyway in language so precise that the answer cannot be used against either of them.
My father calls that afternoon.
"I've heard something," he says, "about a situation involving a physician. Connected to your company." His voice carries the cadence he uses when he has already reached a conclusion and is delivering it rather than discussing it. "I told you sentiment was a liability."
"You did."
"Whatever you are holding onto, release it. That is my professional assessment."
"I understand your assessment."
"Vincent." A pause. "You do not keep variables. You resolve them."
I look at the window. At the street below, which is indifferent to everything happening in this room. "I will speak with you next week," I say.
I end the call.
It is the first time I have ended a call with my father before he was finished speaking. I sit with that for a moment, then set the phone down and go to find Clara.
She is in the chair near the window when I enter, reading something she has written on the notepad I left in the room.
Three lines of what looks like a clinical notation, which means she has been working through the wound management in her head and keeping record of it.
She looks up when the door opens. She does not put the notepad down.
"I want to show you something," I say.
She waits.
"The full KD-9 clinical trial record. Unredacted." I hold her gaze. "Not as a negotiation. Because I want you to understand what I know about what I built."
Her expression does something I cannot name quickly enough to catalog. She sets the notepad down. "All right," she says.
The private research archive is two floors below, in a room that does not appear on the building's official schematics. The data is stored on an isolated server, no external connection, no redundant copy anywhere in the company's main system. I am the only person with access credentials.
I pull up the KD-9 file and step back from the terminal.
She reads the way she handles anything that matters, focused and economical. No unnecessary movement, no audible reaction, occasionally scrolling back to confirm a figure or cross-reference a date. I watch her from across the room, I do not speak.
I have never shown anyone this file. Not Graham, not the board, not the regulatory body that approved the discontinuation based on a summary document I ensured contained nothing that would complicate the approval.
The file contains everything. The full trial data, the efficacy reports, the patient outcome projections for the transition period, the internal communications about the discontinuation decision, and the post-discontinuation mortality review that was conducted internally and never filed externally.
Eight patients died in the six-month window between discontinuation and the identification of an inferior substitute compound.
The review attributed the deaths to disease progression.
The review was written by Helena Sorrell.
I reviewed it before it was filed and made no changes.
I made no revisions, since doing so would have required me to formally acknowledge that the deaths resulted from the decision to discontinue.
That record reaches the regulatory body.
The regulatory body investigates. The investigation finds the same financial projection documents that drove the discontinuation in the first place, and the story takes a shape I was not prepared to give it.
So I made no changes. I approved the filing. I continued.
Clara reads for four hours.
When she finishes, she does not speak immediately.
She sits with the last page on the screen and I can see her working through it.
The clinical mind settling its conclusions into the framework she uses to understand the world.
Not processing grief. Not processing outrage.
Processing mechanism. The same thing she does with every system she encounters.
Tracing what it was designed for, what it accomplished, and whether those outcomes align.
They do not align. She knows this. I know this. We are both sitting with what we know.
Then she looks at me.
"Your company killed eight people in the transition period when this was discontinued," she says.
"Eight people." I let it sit. "In six months. Between discontinuation and an inferior substitute."
Neither of us moves for a long time.
The words sit in the archive room between us, which is the appropriate room for them.
They belong here, in the place that holds the documentation of what happened.
I have been holding this knowledge alone for three years.
I made the decision not to file the mortality review externally.
I am the person the documentation leads back to, and I have known this, and I have continued to operate as though the knowledge existed in a separate compartment from my professional identity.
She has just made that separation impossible. Not by accusing me, by stating a fact.
"You've known for three years," she says.
"Yes."
"And you continued."
"Every quarter, every review cycle, every decision that came after it."
"Why are you showing me this?"
I consider the several available answers. The strategic one. Because her evidence archive likely contains elements of this already and I would rather she see the full picture from me than reconstruct it from fragments. The honest one.
"Because you named what I built," I say.
"At the dinner. You told me I had become the machine and you did not require me to justify it.
I have not been able to put that conversation in its compartment since.
" I hold her gaze. "I wanted someone who would not look away to see what the machine actually did. "
She falls into silence briefly, looking at me with the attention she gives to things she is still deciding how to categorize.
"That is not a strategic reason," she says.
"No."
"It's also not sufficient justification for eight deaths."
"I know that too."
She turns back to the screen. She reads the mortality review one more time.
Helena Sorrell's careful language, the passive constructions, the omissions I did not correct, and then she closes the file.
She does not comment further on it, she does not need to.
The assessment is complete and I received it.
We return to the upper floor. I make tea and pour a second cup for her without being asked because for three days she has had my attention and I know she has been awake since before six.
She takes it.
"The system access you mentioned," she says. "What specifically are you offering?"
"Read access to our active distribution network. Clinical trial classifications. Discontinued compound inventory." I set my cup down. "You would be able to see what we have and where it is."
She studies me. "To what end?"
"Operational efficiency," I say. "You have been navigating our system from the outside for fourteen months. Working with access would reduce the operational risk to both of us."
"That is the strategic answer."
I look at her across the table. "It is also accurate."
"It's not the only reason."
I do not confirm this. I do not deny it. I hold her gaze and she holds mine and the gap between what was said and what was not said sits in the room between us like the third party it has always been.
She sets her cup down. "I'll consider it," she says.
She does not say no. I register this with the care I give to everything about her and place it where I keep the things that matter.